ARCHIVES

Is Everyone in Academic Medicine Unhappy? Or is it Just MD Anderson?

This article is from The Cancer Letter archive.

Vol. 40 No. 46 | December 12, 2014

Download PDF Visit The Full Archive

Related Articles

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

FDA Encourages Study Of Gender Differences

August 6, 1993

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

August 14, 1987

NCA Members To Hear PDQ Issue, Reports On AIDs, Lung Cancer, Cell Invasiveness, Smoking Program, Small Business Grants

September 30, 1983